| Application no. and date | 12785861.1 (espacenet) (Federated) (European Patent Register), 20120517 | | Patent/reg. no. and date | DK/EP 2710031, 20170913 | | Publication date | 20140326 | | Priority no. and date | US 201161487640 P, 20110518, US 201161543716 P, 20111005 | | EP pub. no. and date |
EP 2710031 20140326 | | Effective date | | | Applicant/owner | Mederis Diabetes, LLC, 725 Lynwood Drive
Encinitas, CA 92024, US | | Applicant ref. no. | 63138DK01 | | Inventor | NESTOR, John, J., 725 Lynwood Drive
Encinitas
CA 92024, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 47/60 (2017.01) , A61P 3/10 (2006.01) , C07H 15/04 (2006.01) , C07K 14/605 (2006.01) | | Title | FORBEDREDE PEPTID-LÆGEMIDLER TIL INSULINRESISTENS | | Int. application no. | US2012038434 | | Int. publication no. | WO2012158965 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
